TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
29 hedge funds and large institutions have $42.1M invested in Trillium Therapeutics Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
78% less call options, than puts
Call options by funds: $4K | Put options by funds: $18K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
$4K
Puts
$18K
Top Buyers
| 1 | +$615K | |
| 2 | +$614K | |
| 3 | +$610K | |
| 4 |
Morgan Stanley
New York
|
+$353K |
| 5 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$219K |
Top Sellers
| 1 | -$2.91M | |
| 2 | -$2.09M | |
| 3 | -$1.52M | |
| 4 |
Millennium Management
New York
|
-$16.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.85K |